SureTrader Stock Hero Advertisement
Home > Boards > US Listed > Miscellaneous > Rigel Pharmaceuticals Inc. (RIGL)

7:40AM On The Wires (WIRES) :

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
surf1944 Member Profile
 
Followed By 445
Posts 21,999
Boards Moderated 2
Alias Born 09/11/06
160x600 placeholder
Advertisement
Healthcare stock screen of the month: Price extended, poor fundamentals "Seeking Alpha" - 4/8/2015 1:05:46 PM
Why Rigel Pharmaceuticals Shares Surged Higher Today "The Motley Fool" - 3/31/2015 5:27:36 PM
Additional Proxy Soliciting Materials (definitive) (defa14a) "Edgar (US Regulatory)" - 3/30/2015 5:06:31 PM
Proxy Statement (definitive) (def 14a) "Edgar (US Regulatory)" - 3/30/2015 4:59:36 PM
Confidential Treatment Order (ct Order) "Edgar (US Regulatory)" - 3/18/2015 5:30:43 PM
After Hours Gainers / Losers "Seeking Alpha" - 3/6/2015 5:42:20 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 3/3/2015 4:07:38 PM
Annual Report (10-k) "Edgar (US Regulatory)" - 3/3/2015 1:59:06 PM
Rigel Announces Fourth Quarter and Year End 2014 Financial Results "PR Newswire (US)" - 3/3/2015 7:30:00 AM
Midday Gainers / Losers "Seeking Alpha" - 2/23/2015 12:44:12 PM
Rigel and Bristol-Myers Squibb Announce Research and Development Collaboration for TGF Beta Receptor Kinase Inhibitors for Us... "PR Newswire (US)" - 2/23/2015 8:03:00 AM
Rigel & Bristol-Myers Squibb Announce Research & Development Collaboration for TGF Beta Receptor Kinase Inhibitors for Use in... "Business Wire" - 2/23/2015 8:00:00 AM
Amended Statement of Ownership (sc 13g/a) "Edgar (US Regulatory)" - 2/18/2015 6:09:01 AM
Amended Statement of Ownership (sc 13g/a) "Edgar (US Regulatory)" - 2/17/2015 11:10:51 AM
Lion Biotechnologies Appoints Ryan Maynard Director and Chair of Audit Committee "GlobeNewswire Inc." - 2/17/2015 8:00:00 AM
Amended Statement of Ownership (sc 13g/a) "Edgar (US Regulatory)" - 2/13/2015 10:35:10 AM
Schedule 13g
(sc 13g/a) "Edgar (US Regulatory)" - 2/12/2015 10:54:56 AM
Amended Statement of Ownership (sc 13g/a) "Edgar (US Regulatory)" - 2/9/2015 4:48:15 PM
Amended Statement of Ownership (sc 13g/a) "Edgar (US Regulatory)" - 2/9/2015 2:24:01 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 1/30/2015 4:06:20 PM
Amended Statement of Ownership (sc 13g/a) "Edgar (US Regulatory)" - 1/26/2015 5:20:14 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 1/9/2015 4:16:33 PM
Rigel to Present at the 33rd Annual J.P. Morgan Healthcare Conference "PR Newswire (US)" - 1/8/2015 7:30:00 AM
surf1944   Friday, 05/06/11 09:58:11 AM
Re: surf1944 post# 130
Post # of 326 
7:40AM On The Wires (WIRES) :

Rigel Pharmaceuticals, Inc. (RIGL) announced that the company will assume development of R343, its inhaled syk inhibitor for allergic asthma that recently completed several Phase 1 clinical trials. Pfizer (PFE) is returning full rights to the R343 program as a result of its decision to exit the allergy and respiratory therapeutic area within R&D. Rigel is evaluating the details of R343's development to date and expects to design a Phase 2 clinical trial with R343 later this year.


surf's up......crikey



Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist